Please login to the form below

anaesthetics

This page shows the latest anaesthetics news and features for those working in and with pharma, biotech and healthcare.

Stung by critics, J&J says antidepressant Spravato saves money

It is a single isomer form of ketamine, a low-cost anaesthetic, and ICER says the similarity between the two drugs “raises issues for all stakeholders about how to consider

Latest news

J&J’s Spravato breaks depression drought at FDA

The green light for nasal spray formulation of esketamine – a derivative of the anaesthetic ketamine – is for use of the drug as an add-on to oral antidepressants in people with
Gyroscope's gene therapy given to first dry AMD patient

GT005 was administered under a local anaesthetic by Robert MacLaren, an ophthalmology specialist at Oxford Eye Hospital.
FDA panel backs J&J’s new-class antidepressant

The nasal spray formulation of esketamine – a derivative of the anaesthetic ketamine that has the proposed name Spravato – was backed by a 14-2 vote by an FDA advisory committee yesterday
AcelRX’s potent opioid tablets set to win FDA backing for pain relief

Evaluating the safety and effectiveness of products for use in anaesthesiology and surgery, the Anaesthetic and Analgesic Drug Products Advisory Committee voted 10 to 3 in favour of the drug.
Heron boosted by new data for ‘breakthrough’ pain drug

Shares jumped by a third after trial announcement. Heron Pharma has new data on its combination anaesthetic drug, and a breakthrough designation from the FDA, which suggests it could have an ... Heron’s rival candidate – called HTX-011 – pairs up a

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch October 2016

200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5 injectable pain / anaesthetic products.
Deal Watch September 2016

500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex, Tracrium, Mivacron and Anectinein – excludes US/CA rights].
Deal Watch June 2016

Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
Pharma deals in June 2015

Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management. Collaboration, licence.
Pharma deals during March 2014

Baxter's medical products business has annual sales of over $9bn and a portfolio of intravenous solutions and nutritional therapies, drug delivery systems, premixed and other injectable drugs, inhalation anaesthetics and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

It’s all about patient outcomes… right?

general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed the World.
"Legal highs" ruling leaves illegal labs laughing

These include the anaesthetic nitrous oxide, or laughing gas. . N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
Hayward Medical Communications

Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.
Healthcare 2025: what the future holds for pharma

This was led by major advances in three core areas:. Health: Access to innovative medicines, surgery and anaesthetics, clean air and water.